News Focus
News Focus
icon url

RockRat

04/12/18 9:44 PM

#218470 RE: DewDiligence #218463

Re: GLPG1690 in IPF P3 plan: Speeding along, but risky. Small numbers in P2 - 23 patients! Much shorter treatment period, and it wasn't on top of SOC treatments.

Zoiks!

Regards, RockRat